提速稳定性评估即时复合的阿米洛里德鼻喷雾
Casey L Sayre1,2, Brandon Renninger1, Teja Reaves-Mckee1
1Roseman University of Health Sciences, College of Pharmacy, South Jordan, Utah.
International journal of pharmaceutical compounding
|May 20, 2024
概括
化合物阿米洛里德鼻雾剂显示化学稳定性长达12个月,这表明它有可能治疗焦虑症. 这项研究评估了阿米洛里德鼻喷雾剂的稳定性,这是一种新的焦虑治疗方法.
科学领域:
- 药理学和制药科学 药理学和制药科学
- 神经科学是一个神经科学.
背景情况:
- 美国食品和药物管理局 (FDA) 批准的利尿剂阿米洛里德 (Amiloride) 正在接受治疗焦虑症的研究,因为它具有酸感应离子通道对抗性.
- 鼻腔内阿米洛里德为潜在的焦虑症治疗结果提供了快速的交付.
- 复合鼻腔制剂缺乏制造药物的预制剂特征,需要稳定性评估.
研究的目的:
- 为了评估在6个月和12个月内随时复合的阿米洛里德鼻喷雾的化学稳定性.
- 评估阿米洛里德鼻雾剂与醇的物理稳定性和兼容性.
主要方法:
- 使用高热和阿雷尼乌斯方程的加速降解研究.
- 在12个月内进行稳定性指示高性能液态染色学 (HPLC) 分析.
- 视觉检查,pH值监测和度测量,以确定物理稳定性和兼容性.
主要成果:
- 在12个月的研究期间,阿米洛里德在鼻喷雾配方中表现出化学稳定性.
- 使用阿雷尼乌斯方程的推断支持长期的化学稳定性.
- 证实了与醇的物理稳定性和兼容性.
结论:
- 复合的阿米洛里德鼻喷雾至少在12个月内化学稳定.
- 这些发现支持化合物阿米洛里德鼻喷雾在焦虑症治疗中的潜在用途.
- 对临床疗效的进一步研究是有必要的.
更多相关视频
11:27A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
2.0K
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
841
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
